Abbreviation
|
Full form
|
API |
Active Pharmaceutical Ingredient |
FDA |
Food and Drug Administration |
BCS |
Biopharmaceutics Classification System |
BBB |
Blood Brain Barrier |
IVIVC |
In vitro In vivo Co-relationship |
CYP450 |
Cytochrome P450 |
t1/2
|
Biological half-life |
TI |
Therapeutic Index |
TW |
Therapeutic Window |
MEC |
Minimum effective concentration |
PK |
Pharmacokinetics |
ED50
|
Effective dose in 50% of subjects |
TD50
|
Toxic dose in 50% of subjects |
DDS |
Drug delivery systems |
CRDDS |
Controlled release drug delivery systems |
EPR |
Enhanced permeability and retention |
PLK 1 |
Serine/threonine-protein kinase |
siRNA |
Small interfering Ribose Nucleic acid |
CNTs |
Carbon nanotubes |
SWCNTs |
Single-walled carbon nanotubes |
MWCNTs |
Multiwalled carbon nanotubes |
MMP |
Matrix metallo proteinases |
LCST |
Lower critical solution temperature |
MIP |
Molecularly Imprinted Polymers |
CRISPR Cas9 |
Clustered regularly interspaced short palindromic repeats |
sgRNA
|
Single guide RNA |
LOC |
Lab-on-a-chip |
QD |
Quantun dots |
RES |
Reticulo Endothelial system |